Highlights Navamedic ASA

Equities

NAVA

NO0010205966

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-02 am EDT			5-day change	1st Jan Change
33.6 ^NOK	+3.70%		-1.75%	-8.45%

Apr. 30	Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 13	Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal	Mar. 13	MT
An unknown buyer acquired unknown minority stake in Navamedic ASA (OB:NAVA) from Ingerø Reiten Investment Company As for NOK 95 million.	Mar. 11	CI
Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Navamedic Acquires Rights to Distribute Erectile Dysfunction Treatment in Nordic Countries	Feb. 12	MT
Navamedic ASA Acquires Rights to Market and Distribute Eroxon in the Nordic Countries	Feb. 12	CI
Navamedic ASA Renews Contract Signed with Vitaflo International Limited	Dec. 21	CI
Navamedic Enters Agreement with Orion for Distribution of Parkinson's Drug Across Europe	Dec. 14	MT
Navamedic ASA and Orion Corporation Sign Non-Binding Term Sheet for Flexilev® in Europe	Dec. 13	CI
Navamedic ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Navamedic ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Navamedic Secures Ownership of Sweden’s Sensidose	23-05-26	MT
Navamedic ASA (OB:NAVA) completed the acquisition of Sensidose AB.	23-05-24	CI
EQL Pharma Closes Sensidose Bid, to Accept Navamedic Offer	23-05-17	MT
Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Norway's Navamedic Lifts Offer for Remaining Sensidose Shares	23-05-10	MT
Sweden’s EQL Pharma Increases Bid for Sensidose	23-04-24	MT
Navamedic Raises Takeover Offer for Sensidose, Agrees to Buy 57% Stake	23-04-24	MT
Navamedic Offers to Buy Sensidose for SEK75 Million	23-03-29	MT
Navamedic ASA (OB:NAVA) made an offer to acquire Sensidose AB for SEK 96 million.	23-03-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Navamedic ASA

Equities

NAVA

NO0010205966

Highlights

Filters